medicines

National Cancer Institute Broadens Partnership with Medidata to Bring Unmatched Continuity of Medical and Clinical Data for Lead Protocol Organizations

The Medidata Data Experience offering will enable the National Cancer Institute Lead Protocol Organizations to expedite the development of life-saving…

1 week ago

Xinhua Silk Road: Innovation, tradition deeply integrated on TCM trade fair in China’s Zhangshu City

BEIJING, Oct. 28, 2025 /PRNewswire/ -- China's Zhangshu City, a famed industrial hub of traditional Chinese medicine (TCM) for centuries, has actively…

4 weeks ago

MrMed Expands Its Reach with New Bengaluru Cold-Chain Hub to Improve Access to GLP-1 and Critical Care Medicines

MrMed, India’s largest online super-specialty pharmacy, has opened a state-of-the-art cold-chain distribution hub in Bengaluru. The new facility strengthens the…

1 month ago

Avacta presents first preclinical data from dual payload pre|CISION medicines at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets

First-in-class dual payload peptide drug conjugate delivers two complementary therapies from a single molecule with potential to overcome resistance and…

1 month ago

Accord Plasma B.V. Expands Global Plasma Therapy Capabilities with Acquisition of Prothya Biosolutions

LONDON, Oct. 20, 2025 /PRNewswire/ -- Accord Plasma B.V., a subsidiary of Intas Pharmaceuticals, announced today that it has successfully completed…

1 month ago

Medkart Launches India's First Tool to Find Substitute Medicine and Compare Prices, Transforming Access to Affordable Healthcare

In a significant stride towards affordable healthcare, Medkart Pharmacy has unveiled India's first comprehensive online platform dedicated to comparing your…

1 month ago

Government Push for Generic Drugs Finds Digital Ally in New Healthcare Portal

India's healthcare landscape is undergoing a significant transformation, led by national initiatives like Ayushman Bharat and the Jan Aushadhi Yojana.…

1 month ago

Revolution Medicines Awarded Voucher for Daraxonrasib (RMC-6236) Under FDA Commissioner’s National Priority Voucher Pilot Program

REDWOOD CITY, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing…

2 months ago

Medkart Champions Generic Drug Quality Amid Rising Consumer Concerns

With growing scrutiny around the quality and reliability of generic medicines in India, Medkart, Gujarat’s largest generic-first pharmacy chain, is…

2 months ago